Patents by Inventor Daniel Keith Ness

Daniel Keith Ness has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11191832
    Abstract: The invention provides methods of monitoring immunotherapy directed against alpha-synuclein by comparing a subject's constipation symptoms before treatment and at one or more times during and/or after treatment. The immunotherapeutic regime can be monitored depending on the results of treatment.
    Type: Grant
    Filed: November 19, 2014
    Date of Patent: December 7, 2021
    Assignee: PROTHENA BIOSCIENCES LIMITED
    Inventors: Gene G. Kinney, Theresa Anne Neumann, Daniel Keith Ness
  • Publication number: 20210079103
    Abstract: The invention provides dosage regimes for treatment of synucleinopathies. In one regime, a subject receives 3000-5000 mg of an antibody intravenously every 3-5 weeks. In another regime, a subject receives 1300-1700 mg of an antibody intravenously every 3-5 weeks.
    Type: Application
    Filed: July 23, 2020
    Publication date: March 18, 2021
    Inventors: Jay Soto, Daniel Keith Ness, Martin Koller, Diane Mould, Frank Boess, Meret Martin-Facklam, Valerie Cosson, Hans Peter Grimm, Ronald Gieschke, Sara Belli, Silke Weber
  • Publication number: 20190153102
    Abstract: The invention provides dosage regimes for treatment of synucleinopathies. In one regime, a subject receives 3000-5000 mg of an antibody intravenously every 3-5 weeks. In another regime, a subject receives 1300-1700 mg of an antibody intravenously every 3-5 weeks.
    Type: Application
    Filed: September 28, 2018
    Publication date: May 23, 2019
    Inventors: Jay Soto, Daniel Keith Ness, Martin Koller, Diane Mould, Frank Boess, Meret Martin-Fracklam, Valerie Cosson, Hans Peter Grimm, Ronald Gieschke, Sara Belli, Silke Weber
  • Publication number: 20160279238
    Abstract: The invention provides methods of monitoring immunotherapy directed against alpha-synuclein by comparing a subject's constipation symptoms before treatment and at one or more times during and/or after treatment. The immunotherapeutic regime can be monitored depending on the results of treatment.
    Type: Application
    Filed: November 19, 2014
    Publication date: September 29, 2016
    Inventors: Theresa Anne Neumann, Daniel Keith Ness